Praxis Precision Medicines, Inc.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
PRAX$332.97+19.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $357,329 | $215,372 |
| Marketable securities | 242,002 | 177,195 |
| Prepaid expenses and other current assets | 11,580 | 11,805 |
| Total current assets | 610,911 | 404,372 |
| Long-term marketable securities | 326,757 | 76,961 |
| Property and equipment, net | 147 | 230 |
| Operating lease right-of-use assets | 92 | 1,131 |
| Other non-current assets | — | 416 |
| Total assets | $937,907 | $483,110 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $24,628 | $12,528 |
| Accrued expenses | 35,033 | 23,763 |
| Operating lease liabilities | 110 | 1,259 |
| Total current liabilities | 59,771 | 37,550 |
| Long-term liabilities: | ||
| Non-current portion of operating lease liabilities | — | 110 |
| Total liabilities | 59,771 | 37,660 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of December 31, 2025 and December 31, 2024 | — | — |
| Common stock, $0.0001 par value; 150,000,000 shares authorized; 25,195,092 shares issued and outstanding as of December 31, 2025, and 19,422,358 shares issued and outstanding as of December 31, 2024 | 15 | 14 |
| Additional paid-in capital | 2,017,566 | 1,281,522 |
| Accumulated deficit | (1,140,008) | (836,740) |
| Accumulated other comprehensive gain | 563 | 654 |
| Total stockholders’ equity | 878,136 | 445,450 |
| Total liabilities and stockholders’ equity | $937,907 | $483,110 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.